As of the latest Form 4 filed Jun 22, 2026.
What Belite Bio Inc ADR insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 127 most recent filings for BLTE.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-22 | 2026-06-18 | Scholl Hendrik Peter Chief Medical Officer | SSale | −96.00 | $147.11 | $14.1K | No | Form 4 ↗ |
| 2026-06-22 | 2026-06-18 | Scholl Hendrik Peter, Chief Medical Officer | SSale | −1.20K | $146.24 | $175K | No | Form 4 ↗ |
| 2026-06-22 | 2026-06-18 | Scholl Hendrik Peter, Chief Medical Officer | SSale | −4.86K | $145.43 | $707K | No | Form 4 ↗ |
| 2026-06-22 | 2026-06-18 | Scholl Hendrik Peter, Chief Medical Officer | SSale | −3.75K | $144.66 | $542K | No | Form 4 ↗ |
| 2026-06-22 | 2026-06-18 | Scholl Hendrik Peter, Chief Medical Officer | SSale | −96.00 | $143.90 | $13.8K | No | Form 4 ↗ |
| 2026-06-17 | 2026-06-16 | Scholl Hendrik Peter Chief Medical Officer | SSale | −1.03K | $145.02 | $150K | No | Form 4 ↗ |
| 2026-06-17 | 2026-06-16 | Scholl Hendrik Peter, Chief Medical Officer | SSale | −1.90K | $143.55 | $272K | No | Form 4 ↗ |
| 2026-06-17 | 2026-06-16 | Scholl Hendrik Peter, Chief Medical Officer | SSale | −450.00 | $142.20 | $64.0K | No | Form 4 ↗ |
| 2026-06-17 | 2026-06-16 | Scholl Hendrik Peter, Chief Medical Officer | SSale | −100.00 | $141.83 | $14.2K | No | Form 4 ↗ |
| 2026-06-17 | 2026-06-16 | Scholl Hendrik Peter, Chief Medical Officer | SSale | −540.00 | $140.58 | $75.9K | No | Form 4 ↗ |
| 2026-06-17 | 2026-06-16 | Scholl Hendrik Peter, Chief Medical Officer | SSale | −3.14K | $139.57 | $438K | No | Form 4 ↗ |
| 2026-06-17 | 2026-06-16 | Scholl Hendrik Peter, Chief Medical Officer | SSale | −784.00 | $138.18 | $108K | No | Form 4 ↗ |
| 2026-06-17 | 2026-06-16 | Scholl Hendrik Peter, Chief Medical Officer | SSale | −2.05K | $137.61 | $283K | No | Form 4 ↗ |
| 2026-05-08 | 2026-05-07 | MATA NATHAN L. Chief Scientific Officer | SSale | −9.00 | $155.25 | $1.40K | Yes (planned) | Form 4 ↗ |
| 2026-05-08 | 2026-05-07 | MATA NATHAN L., Chief Scientific Officer | SSale | −3.00 | $154.61 | $463.83 | Yes (planned) | Form 4 ↗ |
| 2026-05-08 | 2026-05-07 | MATA NATHAN L., Chief Scientific Officer | SSale | −428.00 | $153.56 | $65.7K | Yes (planned) | Form 4 ↗ |
| 2026-05-08 | 2026-05-07 | MATA NATHAN L., Chief Scientific Officer | SSale | −226.00 | $152.45 | $34.5K | Yes (planned) | Form 4 ↗ |
| 2026-05-07 | 2026-05-06 | MATA NATHAN L. Chief Scientific Officer | SSale | −100.00 | $156.00 | $15.6K | Yes (planned) | Form 4 ↗ |
| 2026-05-07 | 2026-05-06 | MATA NATHAN L., Chief Scientific Officer | SSale | −100.00 | $155.97 | $15.6K | Yes (planned) | Form 4 ↗ |
| 2026-05-07 | 2026-05-06 | MATA NATHAN L., Chief Scientific Officer | SSale | −240.00 | $154.41 | $37.1K | Yes (planned) | Form 4 ↗ |
| 2026-05-07 | 2026-05-06 | MATA NATHAN L., Chief Scientific Officer | SSale | −128.00 | $153.42 | $19.6K | Yes (planned) | Form 4 ↗ |
| 2026-05-07 | 2026-05-06 | MATA NATHAN L., Chief Scientific Officer | SSale | −424.00 | $152.67 | $64.7K | Yes (planned) | Form 4 ↗ |
| 2026-05-07 | 2026-05-06 | MATA NATHAN L., Chief Scientific Officer | SSale | −8.00 | $151.57 | $1.21K | Yes (planned) | Form 4 ↗ |
| 2026-05-06 | 2026-05-05 | MATA NATHAN L. Chief Scientific Officer | SSale | −68.00 | $158.11 | $10.8K | Yes (planned) | Form 4 ↗ |
| 2026-05-06 | 2026-05-05 | MATA NATHAN L., Chief Scientific Officer | SSale | −155.00 | $157.29 | $24.4K | Yes (planned) | Form 4 ↗ |
| 2026-05-06 | 2026-05-05 | MATA NATHAN L., Chief Scientific Officer | SSale | −121.00 | $156.53 | $18.9K | Yes (planned) | Form 4 ↗ |
| 2026-05-06 | 2026-05-05 | MATA NATHAN L., Chief Scientific Officer | SSale | −173.00 | $155.48 | $26.9K | Yes (planned) | Form 4 ↗ |
| 2026-05-06 | 2026-05-05 | MATA NATHAN L., Chief Scientific Officer | SSale | −363.00 | $154.44 | $56.1K | Yes (planned) | Form 4 ↗ |
| 2026-05-06 | 2026-05-05 | MATA NATHAN L., Chief Scientific Officer | SSale | −120.00 | $153.92 | $18.5K | Yes (planned) | Form 4 ↗ |
| 2026-05-05 | 2026-05-04 | MATA NATHAN L. Chief Scientific Officer | SSale | −172.00 | $157.49 | $27.1K | Yes (planned) | Form 4 ↗ |
| 2026-05-05 | 2026-05-04 | MATA NATHAN L., Chief Scientific Officer | SSale | −235.00 | $156.57 | $36.8K | Yes (planned) | Form 4 ↗ |
| 2026-05-05 | 2026-05-04 | MATA NATHAN L., Chief Scientific Officer | SSale | −325.00 | $155.21 | $50.4K | Yes (planned) | Form 4 ↗ |
| 2026-05-05 | 2026-05-04 | MATA NATHAN L., Chief Scientific Officer | SSale | −236.00 | $154.24 | $36.4K | Yes (planned) | Form 4 ↗ |
| 2026-05-05 | 2026-05-04 | MATA NATHAN L., Chief Scientific Officer | SSale | −32.00 | $153.50 | $4.91K | Yes (planned) | Form 4 ↗ |
| 2026-05-04 | 2026-05-01 | MATA NATHAN L. Chief Scientific Officer | SSale | −23.00 | $160.00 | $3.68K | Yes (planned) | Form 4 ↗ |
| 2026-05-04 | 2026-05-01 | MATA NATHAN L., Chief Scientific Officer | SSale | −38.00 | $159.08 | $6.04K | Yes (planned) | Form 4 ↗ |
| 2026-05-04 | 2026-05-01 | MATA NATHAN L., Chief Scientific Officer | SSale | −65.00 | $158.35 | $10.3K | Yes (planned) | Form 4 ↗ |
| 2026-05-04 | 2026-05-01 | MATA NATHAN L., Chief Scientific Officer | SSale | −106.00 | $157.45 | $16.7K | Yes (planned) | Form 4 ↗ |
| 2026-05-04 | 2026-05-01 | MATA NATHAN L., Chief Scientific Officer | SSale | −82.00 | $156.24 | $12.8K | Yes (planned) | Form 4 ↗ |
| 2026-05-04 | 2026-05-01 | MATA NATHAN L., Chief Scientific Officer | SSale | −346.00 | $155.48 | $53.8K | Yes (planned) | Form 4 ↗ |
| 2026-05-04 | 2026-05-01 | MATA NATHAN L., Chief Scientific Officer | SSale | −288.00 | $154.38 | $44.5K | Yes (planned) | Form 4 ↗ |
| 2026-05-04 | 2026-05-01 | MATA NATHAN L., Chief Scientific Officer | SSale | −52.00 | $153.89 | $8.00K | Yes (planned) | Form 4 ↗ |
| 2026-05-01 | 2026-04-30 | MATA NATHAN L. Chief Scientific Officer | SSale | −101.00 | $158.15 | $16.0K | Yes (planned) | Form 4 ↗ |
| 2026-05-01 | 2026-04-30 | MATA NATHAN L., Chief Scientific Officer | SSale | −340.00 | $157.37 | $53.5K | Yes (planned) | Form 4 ↗ |
| 2026-05-01 | 2026-04-30 | MATA NATHAN L., Chief Scientific Officer | SSale | −517.00 | $156.59 | $81.0K | Yes (planned) | Form 4 ↗ |
| 2026-05-01 | 2026-04-30 | MATA NATHAN L., Chief Scientific Officer | SSale | −42.00 | $155.68 | $6.54K | Yes (planned) | Form 4 ↗ |
| 2026-04-30 | 2026-04-29 | MATA NATHAN L. Chief Scientific Officer | SSale | −22.00 | $158.19 | $3.48K | Yes (planned) | Form 4 ↗ |
| 2026-04-30 | 2026-04-29 | MATA NATHAN L., Chief Scientific Officer | SSale | −102.00 | $157.39 | $16.1K | Yes (planned) | Form 4 ↗ |
| 2026-04-30 | 2026-04-29 | MATA NATHAN L., Chief Scientific Officer | SSale | −339.00 | $156.43 | $53.0K | Yes (planned) | Form 4 ↗ |
| 2026-04-30 | 2026-04-29 | MATA NATHAN L., Chief Scientific Officer | SSale | −259.00 | $155.52 | $40.3K | Yes (planned) | Form 4 ↗ |
| 2026-04-30 | 2026-04-29 | MATA NATHAN L., Chief Scientific Officer | SSale | −278.00 | $154.58 | $43.0K | Yes (planned) | Form 4 ↗ |
| 2026-04-29 | 2026-04-28 | MATA NATHAN L. Chief Scientific Officer | SSale | −54.00 | $162.14 | $8.76K | Yes (planned) | Form 4 ↗ |
| 2026-04-29 | 2026-04-28 | MATA NATHAN L., Chief Scientific Officer | SSale | −89.00 | $161.72 | $14.4K | Yes (planned) | Form 4 ↗ |
| 2026-04-29 | 2026-04-28 | MATA NATHAN L., Chief Scientific Officer | SSale | −120.00 | $160.27 | $19.2K | Yes (planned) | Form 4 ↗ |
| 2026-04-29 | 2026-04-28 | MATA NATHAN L., Chief Scientific Officer | SSale | −380.00 | $159.42 | $60.6K | Yes (planned) | Form 4 ↗ |
| 2026-04-29 | 2026-04-28 | MATA NATHAN L., Chief Scientific Officer | SSale | −62.00 | $158.71 | $9.84K | Yes (planned) | Form 4 ↗ |
| 2026-04-29 | 2026-04-28 | MATA NATHAN L., Chief Scientific Officer | SSale | −222.00 | $157.49 | $35.0K | Yes (planned) | Form 4 ↗ |
| 2026-04-29 | 2026-04-28 | MATA NATHAN L., Chief Scientific Officer | SSale | −53.00 | $156.61 | $8.30K | Yes (planned) | Form 4 ↗ |
| 2026-04-29 | 2026-04-28 | MATA NATHAN L., Chief Scientific Officer | SSale | −8.00 | $155.36 | $1.24K | Yes (planned) | Form 4 ↗ |
| 2026-04-29 | 2026-04-28 | MATA NATHAN L., Chief Scientific Officer | SSale | −12.00 | $154.65 | $1.86K | Yes (planned) | Form 4 ↗ |
| 2026-04-28 | 2026-04-27 | MATA NATHAN L. Chief Scientific Officer | SSale | −36.00 | $164.07 | $5.91K | Yes (planned) | Form 4 ↗ |
| 2026-04-28 | 2026-04-27 | MATA NATHAN L., Chief Scientific Officer | SSale | −409.00 | $163.56 | $66.9K | Yes (planned) | Form 4 ↗ |
| 2026-04-28 | 2026-04-27 | MATA NATHAN L., Chief Scientific Officer | SSale | −231.00 | $162.38 | $37.5K | Yes (planned) | Form 4 ↗ |
| 2026-04-28 | 2026-04-27 | MATA NATHAN L., Chief Scientific Officer | SSale | −280.00 | $161.62 | $45.3K | Yes (planned) | Form 4 ↗ |
| 2026-04-28 | 2026-04-27 | MATA NATHAN L., Chief Scientific Officer | SSale | −44.00 | $160.83 | $7.08K | Yes (planned) | Form 4 ↗ |
| 2026-04-27 | 2026-04-24 | MATA NATHAN L. Chief Scientific Officer | SSale | −3.00 | $162.53 | $487.59 | Yes (planned) | Form 4 ↗ |
| 2026-04-27 | 2026-04-24 | MATA NATHAN L., Chief Scientific Officer | SSale | −28.00 | $161.22 | $4.51K | Yes (planned) | Form 4 ↗ |
| 2026-04-27 | 2026-04-24 | MATA NATHAN L., Chief Scientific Officer | SSale | −330.00 | $160.40 | $52.9K | Yes (planned) | Form 4 ↗ |
| 2026-04-27 | 2026-04-24 | MATA NATHAN L., Chief Scientific Officer | SSale | −375.00 | $159.46 | $59.8K | Yes (planned) | Form 4 ↗ |
| 2026-04-27 | 2026-04-24 | MATA NATHAN L., Chief Scientific Officer | SSale | −190.00 | $158.65 | $30.1K | Yes (planned) | Form 4 ↗ |
| 2026-04-27 | 2026-04-24 | MATA NATHAN L., Chief Scientific Officer | SSale | −74.00 | $157.86 | $11.7K | Yes (planned) | Form 4 ↗ |
| 2026-04-24 | 2026-04-23 | MATA NATHAN L. Chief Scientific Officer | SSale | −21.00 | $169.56 | $3.56K | Yes (planned) | Form 4 ↗ |
| 2026-04-24 | 2026-04-23 | MATA NATHAN L., Chief Scientific Officer | SSale | −54.00 | $168.43 | $9.10K | Yes (planned) | Form 4 ↗ |
| 2026-04-24 | 2026-04-23 | MATA NATHAN L., Chief Scientific Officer | SSale | −373.00 | $167.37 | $62.4K | Yes (planned) | Form 4 ↗ |
| 2026-04-24 | 2026-04-23 | MATA NATHAN L., Chief Scientific Officer | SSale | −127.00 | $166.56 | $21.2K | Yes (planned) | Form 4 ↗ |
| 2026-04-24 | 2026-04-23 | MATA NATHAN L., Chief Scientific Officer | SSale | −158.00 | $165.38 | $26.1K | Yes (planned) | Form 4 ↗ |
| 2026-04-24 | 2026-04-23 | MATA NATHAN L., Chief Scientific Officer | SSale | −267.00 | $164.47 | $43.9K | Yes (planned) | Form 4 ↗ |
| 2026-04-23 | 2026-04-22 | MATA NATHAN L. Chief Scientific Officer | SSale | −21.00 | $173.04 | $3.63K | Yes (planned) | Form 4 ↗ |
| 2026-04-23 | 2026-04-22 | MATA NATHAN L., Chief Scientific Officer | SSale | −249.00 | $172.49 | $43.0K | Yes (planned) | Form 4 ↗ |
| 2026-04-23 | 2026-04-22 | MATA NATHAN L., Chief Scientific Officer | SSale | −257.00 | $171.62 | $44.1K | Yes (planned) | Form 4 ↗ |
| 2026-04-23 | 2026-04-22 | MATA NATHAN L., Chief Scientific Officer | SSale | −75.00 | $170.58 | $12.8K | Yes (planned) | Form 4 ↗ |
| 2026-04-23 | 2026-04-22 | MATA NATHAN L., Chief Scientific Officer | SSale | −105.00 | $169.52 | $17.8K | Yes (planned) | Form 4 ↗ |
| 2026-04-23 | 2026-04-22 | MATA NATHAN L., Chief Scientific Officer | SSale | −101.00 | $168.64 | $17.0K | Yes (planned) | Form 4 ↗ |
| 2026-04-23 | 2026-04-22 | MATA NATHAN L., Chief Scientific Officer | SSale | −141.00 | $167.42 | $23.6K | Yes (planned) | Form 4 ↗ |
| 2026-04-23 | 2026-04-22 | MATA NATHAN L., Chief Scientific Officer | SSale | −20.00 | $166.32 | $3.33K | Yes (planned) | Form 4 ↗ |
| 2026-04-23 | 2026-04-22 | MATA NATHAN L., Chief Scientific Officer | SSale | −31.00 | $165.70 | $5.14K | Yes (planned) | Form 4 ↗ |
| 2026-04-23 | 2026-04-21 | Lin Yu-Hsin Chief Executive Officer | JOther | +10.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-23 | 2026-04-21 | Chuang Hao-Yuan Chief Financial Officer | JOther | +10.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-22 | 2026-04-21 | MATA NATHAN L. Chief Scientific Officer | SSale | −214.00 | $167.34 | $35.8K | Yes (planned) | Form 4 ↗ |
| 2026-04-22 | 2026-04-21 | MATA NATHAN L., Chief Scientific Officer | SSale | −312.00 | $166.49 | $51.9K | Yes (planned) | Form 4 ↗ |
| 2026-04-22 | 2026-04-21 | MATA NATHAN L., Chief Scientific Officer | SSale | −332.00 | $165.49 | $54.9K | Yes (planned) | Form 4 ↗ |
| 2026-04-22 | 2026-04-21 | MATA NATHAN L., Chief Scientific Officer | SSale | −78.00 | $164.60 | $12.8K | Yes (planned) | Form 4 ↗ |
| 2026-04-22 | 2026-04-21 | MATA NATHAN L., Chief Scientific Officer | SSale | −64.00 | $163.49 | $10.5K | Yes (planned) | Form 4 ↗ |
| 2026-04-21 | 2026-04-20 | MATA NATHAN L. Chief Scientific Officer | SSale | −9.00 | $168.35 | $1.52K | Yes (planned) | Form 4 ↗ |
| 2026-04-21 | 2026-04-20 | MATA NATHAN L., Chief Scientific Officer | SSale | −16.00 | $167.17 | $2.67K | Yes (planned) | Form 4 ↗ |
| 2026-04-21 | 2026-04-20 | MATA NATHAN L., Chief Scientific Officer | SSale | −3.00 | $166.91 | $500.72 | Yes (planned) | Form 4 ↗ |
| 2026-04-21 | 2026-04-20 | MATA NATHAN L., Chief Scientific Officer | SSale | −40.00 | $165.29 | $6.61K | Yes (planned) | Form 4 ↗ |
| 2026-04-21 | 2026-04-20 | MATA NATHAN L., Chief Scientific Officer | SSale | −124.00 | $164.40 | $20.4K | Yes (planned) | Form 4 ↗ |
| 2026-04-21 | 2026-04-20 | MATA NATHAN L., Chief Scientific Officer | SSale | −524.00 | $163.52 | $85.7K | Yes (planned) | Form 4 ↗ |
| 2026-04-21 | 2026-04-20 | MATA NATHAN L., Chief Scientific Officer | SSale | −284.00 | $162.76 | $46.2K | Yes (planned) | Form 4 ↗ |
| 2026-04-20 | 2026-04-17 | MATA NATHAN L. Chief Scientific Officer | SSale | −200.00 | $163.33 | $32.7K | Yes (planned) | Form 4 ↗ |
| 2026-04-20 | 2026-04-17 | MATA NATHAN L., Chief Scientific Officer | SSale | −216.00 | $162.48 | $35.1K | Yes (planned) | Form 4 ↗ |
| 2026-04-20 | 2026-04-17 | MATA NATHAN L., Chief Scientific Officer | SSale | −274.00 | $161.41 | $44.2K | Yes (planned) | Form 4 ↗ |
| 2026-04-20 | 2026-04-17 | MATA NATHAN L., Chief Scientific Officer | SSale | −226.00 | $160.55 | $36.3K | Yes (planned) | Form 4 ↗ |
| 2026-04-20 | 2026-04-17 | MATA NATHAN L., Chief Scientific Officer | SSale | −52.00 | $159.38 | $8.29K | Yes (planned) | Form 4 ↗ |
| 2026-04-20 | 2026-04-17 | MATA NATHAN L., Chief Scientific Officer | SSale | −32.00 | $158.46 | $5.07K | Yes (planned) | Form 4 ↗ |
| 2026-04-20 | 2026-04-16 | MATA NATHAN L. Chief Scientific Officer | SSale | −12.00 | $164.12 | $1.97K | Yes (planned) | Form 4 ↗ |
| 2026-04-20 | 2026-04-16 | MATA NATHAN L., Chief Scientific Officer | SSale | −36.00 | $163.21 | $5.88K | Yes (planned) | Form 4 ↗ |
| 2026-04-20 | 2026-04-16 | MATA NATHAN L., Chief Scientific Officer | SSale | −76.00 | $162.26 | $12.3K | Yes (planned) | Form 4 ↗ |
| 2026-04-20 | 2026-04-16 | MATA NATHAN L., Chief Scientific Officer | SSale | −240.00 | $161.61 | $38.8K | Yes (planned) | Form 4 ↗ |
| 2026-04-20 | 2026-04-16 | MATA NATHAN L., Chief Scientific Officer | SSale | −201.00 | $160.35 | $32.2K | Yes (planned) | Form 4 ↗ |
| 2026-04-20 | 2026-04-16 | MATA NATHAN L., Chief Scientific Officer | SSale | −219.00 | $159.81 | $35.0K | Yes (planned) | Form 4 ↗ |
| 2026-04-20 | 2026-04-16 | MATA NATHAN L., Chief Scientific Officer | SSale | −216.00 | $158.28 | $34.2K | Yes (planned) | Form 4 ↗ |
| 2026-04-16 | 2026-04-15 | MATA NATHAN L. Chief Scientific Officer | SSale | −4.00 | $171.19 | $684.76 | Yes (planned) | Form 4 ↗ |
| 2026-04-16 | 2026-04-15 | MATA NATHAN L., Chief Scientific Officer | SSale | −8.00 | $170.77 | $1.37K | Yes (planned) | Form 4 ↗ |
| 2026-04-16 | 2026-04-15 | MATA NATHAN L., Chief Scientific Officer | SSale | −68.00 | $169.15 | $11.5K | Yes (planned) | Form 4 ↗ |
| 2026-04-16 | 2026-04-15 | MATA NATHAN L., Chief Scientific Officer | SSale | −537.00 | $168.64 | $90.6K | Yes (planned) | Form 4 ↗ |
| 2026-04-16 | 2026-04-15 | MATA NATHAN L., Chief Scientific Officer | SSale | −383.00 | $167.58 | $64.2K | Yes (planned) | Form 4 ↗ |
| 2026-04-13 | 2026-04-09 | Lin Yu-Hsin Chief Executive Officer | SSale | −200.00 | $183.00 | $36.6K | Yes (planned) | Form 4 ↗ |
| 2026-04-13 | 2026-04-09 | Lin Yu-Hsin, Chief Executive Officer | SSale | −3.00K | $182.40 | $547K | Yes (planned) | Form 4 ↗ |
| 2026-04-13 | 2026-04-09 | Lin Yu-Hsin, Chief Executive Officer | SSale | −3.50K | $181.33 | $635K | Yes (planned) | Form 4 ↗ |
| 2026-04-13 | 2026-04-09 | Lin Yu-Hsin, Chief Executive Officer | SSale | −2.50K | $180.36 | $451K | Yes (planned) | Form 4 ↗ |
| 2026-04-13 | 2026-04-09 | Chen Wan-Shan Director | SSale | −1.10K | $180.43 | $198K | Yes (planned) | Form 4 ↗ |
| 2026-04-13 | 2026-04-09 | Chuang Hao-Yuan Chief Financial Officer | SSale | −291.00 | $183.08 | $53.3K | Yes (planned) | Form 4 ↗ |
| 2026-04-13 | 2026-04-09 | Chuang Hao-Yuan, Chief Financial Officer | SSale | −1.91K | $182.58 | $349K | Yes (planned) | Form 4 ↗ |
| 2026-04-13 | 2026-04-09 | Chuang Hao-Yuan, Chief Financial Officer | SSale | −2.00K | $181.40 | $363K | Yes (planned) | Form 4 ↗ |
| 2026-04-13 | 2026-04-09 | Chuang Hao-Yuan, Chief Financial Officer | SSale | −2.00K | $180.35 | $361K | Yes (planned) | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also BLTE’s full analysis or the market-wide insider trading feed. The tabs above jump to BLTE’s other SEC data.
Source: SEC Form 4 filings for BLTE, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.